Xeris Biopharma Announces Private Convertible Note Exchange Transactions

27.09.2023 - Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a range of therapies, today announced that on September ... Seite 1

Related Keywords

Steven Pieper ,Exchange Agreements ,Xeris Biopharma Holdings Inc ,Xeris Pharmaceuticals Inc ,Exchange Transactions ,Nasdaq ,Xeris Biopharma Holdings ,Xeris Pharmaceuticals ,Convertible Senior Notes ,Existing Notes ,Securities Act ,Xeri Chief Financial ,New Notes ,Xeris Biopharma Holdings Chart ,Eris Biopharma Holdings Kurs ,Eris Biopharma Holdings Aktie ,